SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist.

Bozonnat A, Assan F, LeGoff J, Bourrat E, Bachelez H.

Source : J Clin Immunol

2021 Oct 1

Pmid : 34176064